Dr.Surbhi Kansal, and Mainsha Jain. 2026. “IN VITRO SUSCEPTIBILITY PROFILES OF FTOLOZANE–TAZOBACTAM AND CEFTAZIDIME–AVIBACTAM AGAINST AMPC ESBL PRODUCING ENTEROBACTERIACEAE”. Journal of Population Therapeutics and Clinical Pharmacology 33 (2): 841-52. https://doi.org/10.69980/1gsrfr34.